Literature DB >> 23225898

The dengue human challenge model: has the time come to accept this challenge?

Anna P Durbin, Stephen S Whitehead.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23225898     DOI： 10.1093/infdis/jis749

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  12 in total

Review 1.  Review article: Research on dengue during World War II revisited.

Authors:  Grace E Snow; Benjamin Haaland; Eng Eong Ooi; Duane J Gubler
Journal:  Am J Trop Med Hyg       Date:  2014-10-13       Impact factor: 2.345

Review 2.  Controlled Human Infection Models To Accelerate Vaccine Development.

Authors:  Robert K M Choy; A Louis Bourgeois; Christian F Ockenhouse; Richard I Walker; Rebecca L Sheets; Jorge Flores
Journal:  Clin Microbiol Rev       Date:  2022-07-06       Impact factor: 50.129

3.  Economic Burden of Dengue Virus Infection at the Household Level Among Residents of Puerto Maldonado, Peru.

Authors:  Gabriela Salmon-Mulanovich; David L Blazes; Andres G Lescano; Daniel G Bausch; Joel M Montgomery; William K Pan
Journal:  Am J Trop Med Hyg       Date:  2015-07-27       Impact factor: 2.345

Review 4.  Dengue vaccines: recent developments, ongoing challenges and current candidates.

Authors:  Monica A McArthur; Marcelo B Sztein; Robert Edelman
Journal:  Expert Rev Vaccines       Date:  2013-08       Impact factor: 5.217

5.  Live attenuated tetravalent dengue virus host range vaccine is immunogenic in African green monkeys following a single vaccination.

Authors:  Caitlin M Briggs; Katherine M Smith; Amanda Piper; Emerson Huitt; Carla J Spears; Michelle Quiles; Mariana Ribeiro; Malcolm E Thomas; Dennis T Brown; Raquel Hernandez
Journal:  J Virol       Date:  2014-04-02       Impact factor: 5.103

6.  Immunotranscriptomic profiling the acute and clearance phases of a human challenge dengue virus serotype 2 infection model.

Authors:  John P Hanley; Huy A Tu; Julie A Dragon; Dorothy M Dickson; Roxana Del Rio-Guerra; Scott W Tighe; Korin M Eckstrom; Nicholas Selig; Samuel V Scarpino; Stephen S Whitehead; Anna P Durbin; Kristen K Pierce; Beth D Kirkpatrick; Donna M Rizzo; Seth Frietze; Sean A Diehl
Journal:  Nat Commun       Date:  2021-05-24       Impact factor: 17.694

Review 7.  Mouse models to study dengue virus immunology and pathogenesis.

Authors:  Raphaël M Zellweger; Sujan Shresta
Journal:  Front Immunol       Date:  2014-04-10       Impact factor: 7.561

8.  Role of humoral versus cellular responses induced by a protective dengue vaccine candidate.

Authors:  Raphaël M Zellweger; Robyn Miller; William E Eddy; Laura J White; Robert E Johnston; Sujan Shresta
Journal:  PLoS Pathog       Date:  2013-10-31       Impact factor: 6.823

9.  In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination.

Authors:  Stephen S Whitehead; Anna P Durbin; Kristen K Pierce; Dan Elwood; Benjamin D McElvany; Ellen A Fraser; Marya P Carmolli; Cecilia M Tibery; Noreen A Hynes; Matthew Jo; Janece M Lovchik; Catherine J Larsson; Elena A Doty; Dorothy M Dickson; Catherine J Luke; Kanta Subbarao; Sean A Diehl; Beth D Kirkpatrick
Journal:  PLoS Negl Trop Dis       Date:  2017-05-08

Review 10.  Vaccine-mediated immunity against dengue and the potential for long-term protection against disease.

Authors:  Mark K Slifka
Journal:  Front Immunol       Date:  2014-05-06       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.